Fairmount Funds Management LLC 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:46 pm Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,360,077 4.900% | 15,097 (+0.64%) | Filing |
| 2023-07-07 4:00 pm Purchase | 2023-06-28 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,344,980 5.000% | 333,333 (+16.57%) | Filing |
| 2023-02-14 3:45 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,011,647 4.600% | -155,000 (-7.15%) | Filing |
| 2022-10-25 9:09 pm Purchase | 2022-09-16 | 13G | Axsome Therapeutics, Inc. AXSM | Fairmount Funds Management LLC | 2,166,647 5.400% | 2,166,647 (New Position) | Filing |